Results 1 to 10 of about 5,922 (152)
Kaposi’s Sarcoma-associated herpesvirus microRNAs [PDF]
Frontiers in Microbiology, 2012 Kaposi’s Sarcoma-associated herpesvirus (KSHV) is a human pathogenic -herpesvirus strongly associated with the development of Kaposi’s Sarcoma and B cell proliferative disorders, including primary effusion lymphoma (PEL).
Eva eGottwein
doaj +3 more sources
Kaposi's sarcoma-associated herpesvirus at 27
Tumour Virus Research, 2021 Kaposi's sarcoma-associated herpesvirus (KSHV) was discovered 27 years ago and its link to several pathologies – Kaposi's sarcoma, primary effusion lymphoma, and the B cell variant of Multicentric Castleman disease – is now well established.
Marta Maria Gaglia
doaj +3 more sources
Pathology of Kaposi's sarcoma-associated herpesvirus infection [PDF]
Frontiers in Microbiology, 2011 Kaposi’s sarcoma-associated herpesvirus (KSHV, human herpesvirus 8, HHV-8) is a human herpesvirus, classified as a gamma-herpesvirus. KSHV is detected in Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and some cases of multicentric Castleman’s ...
Hitomi eFukumoto +4 more
doaj +3 more sources
Kaposi’s Sarcoma-associated Herpesvirus
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2016 Background: Kaposi’s sarcoma (KS) revealed by Moritz Kaposi first time in 1872. In the early 1980, the prevalence of SK began to increase dramatically.
Novia Indriyani Adisty +2 more
doaj +2 more sources
Epidemiology and pathogenesis of Kaposi's sarcoma–associated herpesvirus [PDF]
Philosophical Transactions of the Royal Society B: Biological Sciences, 2001 Kaposi's sarcoma (KS) occurs in Europe and the Mediterranean countries (classic KS) and Africa (endemic KS), immunosuppressed patients (iatrogenic or post–transplant KS) and those with acquired immunodeficiency syndrome (AIDS), especially among those who acquired human immunodeficiency virus sexually (AIDS–KS). KS–associated herpesvirus (KSHV or HHV–8)
Chris Boshoff, R A Weiss
exaly +3 more sources
Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil [PDF]
Brazilian Journal of Medical and Biological Research, 2006 Kaposi's sarcoma (KS) became a critical health issue with the emergence of acquired immunodeficiency syndrome (AIDS) in the 1980s. Four clinical-epidemiological forms of KS have been described: classical KS, endemic KS, iatrogenic KS, and AIDS-associated
S. Ramos-da-Silva +3 more
doaj +6 more sources
Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus [PDF]
Viruses, 2014 This review summarizes the current knowledge pertaining to Kaposi sarcoma-associated herpesvirus (KSHV) epidemiology and transmission. Since the identification of KSHV twenty years ago, it is now known to be associated with Kaposi’s sarcoma (KS ...
Veenu Minhas, Charles Wood
doaj +3 more sources
Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis [PDF]
mBio, 2018 Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiologic agent for Kaposi’s sarcoma (KS), which is one of the most common HIV-associated neoplasms.
Hye-Ra Lee +8 more
doaj +5 more sources
The Chromatin Landscape of Kaposi’s Sarcoma-Associated Herpesvirus [PDF]
Viruses, 2013 Kaposi’s sarcoma-associated herpesvirus is an oncogenic γ-herpesvirus that causes latent infection in humans. In cells, the viral genome adopts a highly organized chromatin structure, which is controlled by a wide variety of cellular and viral chromatin ...
Zsolt Toth, Kevin Brulois, Jae U. Jung
doaj +3 more sources
Dendritic cells: Key players in human herpesvirus 8 infection and pathogenesis [PDF]
Frontiers in Microbiology, 2014 Human herpesvirus 8 (HHV-8; Kaposi’s sarcoma-associated herpesvirus) is an oncogenic gammaherpesvirus that primarily infects cells of the immune and vascular systems.
Diana M. Campbell +5 more
doaj +3 more sources